In vitro activity of WQ-3810, a novel fluoroquinolone, against multidrug-resistant and fluoroquinolone-resistant pathogens

International Journal of Antimicrobial Agents

Volumn 44, Issue 5, 2014, Pages 443-449

  Kazamori, Daichi ^a   Aoi, Hiroshi ^a   Sugimoto, Kaori ^a   Ueshima, Taichi ^a   Amano, Hirotaka ^a   Itoh, Kenji ^a   Kuramoto, Yasuhiro ^a   Yazaki, Akira ^a  

^a WAKUNAGA PHARMACEUTICAL CO LTD   (Japan)

Author keywords

Antimicrobial resistance; Fluoroquinolones; WQ 3810

Indexed keywords

BACTERIAL DNA; CIPROFLOXACIN; DNA TOPOISOMERASE (ATP HYDROLYSING); DNA TOPOISOMERASE IV; GEMIFLOXACIN; LEVOFLOXACIN; MOXIFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; UNCLASSIFIED DRUG; WQ 3810; ANTIINFECTIVE AGENT; QUINOLONE DERIVATIVE;

ACINETOBACTER BAUMANNII; AMINO ACID ANALYSIS; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIUM ISOLATE; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENCY; DRUG STRUCTURE; DRUG TARGETING; ENZYME INHIBITION; ESCHERICHIA COLI; IN VITRO STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NEISSERIA GONORRHOEAE; NONHUMAN; STREPTOCOCCUS PNEUMONIAE; DRUG EFFECTS; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; MICROBIAL SENSITIVITY TEST;

ANTI-BACTERIAL AGENTS; DNA GYRASE; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FLUOROQUINOLONES; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HUMANS; MICROBIAL SENSITIVITY TESTS;

EID: 84908459562     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2014.07.017     Document Type: Article

References (30)

1. H. Koga, A. Itoh, S. Murayama, S. Suzue, and T. Irikura Structure-activity relationships of antibacterial 6,7- and 7,8-disubstituted 1-alkyl-1,4-dihydro-4-oxoquinolone-3-carboxylic acids J Med Chem 23 1980 1358 1363
2. G.G. Zhanel, M. DeCorby, K.A. Nichol, A. Wierzbowski, P.J. Baudry, and J.A. Karlowsky Antimicrobial susceptibility of 3931 organisms isolated from intensive care units in Canada: Canadian National Intensive Care Unit Study, 2005/2006 Diagn Microbiol Infect Dis 62 2008 67 80
3. S.R. Lockhart, M.A. Abramson, S.E. Beekmann, G. Gallagher, S. Riedel, and D.J. Diekema Antimicrobial resistance among Gram-negative bacilli causing infections in intensive care unit patients in the United States between 1993 and 2004 J Clin Microbiol 45 2007 3352 3359
4. E.A. Donegan, D.N. Wirawan, P. Muliawan, J. Schachter, J. Moncada, and M. Parekh Fluoroquinolone-resistant Neisseria gonorrhoeae in Bali, Indonesia: 2004 Sex Transm Dis 33 2006 625 629
5. K. Drlica, and X. Zhao DNA gyrase, topoisomerase IV, and the 4-quinolones Microbiol Mol Biol Rev 61 1997 377 392
6. D.C. Hooper Bacterial topoisomerases, anti-topoisomerases, and anti-topoisomerase resistance Clin Infect Dis 27 1998 S54 S63
7. D.C. Hooper Emerging mechanisms of fluoroquinolone resistance Emerg Infect Dis 7 2001 337 341
8. H. Fukuda, S. Hori, and K. Hiramatsu Antibacterial activity of gatifloxacin (AM-1155, CG5501, BMS-206584), a newly developed fluoroquinolone, against sequentially acquired quinolone-resistant mutants and the norA transformant of Staphylococcus aureus Antimicrob Agents Chemother 42 1998 1917 1922
9. N. Masuda, E. Sakagawa, S. Ohya, N. Gotoh, H. Tsujimoto, and T. Nishino Substrate specificities of MexAB-OprM, MexCD-OprJ, and MexXY-OprM efflux pumps in Pseudomonas aeruginosa Antimicrob Agents Chemother 44 2000 3322 3327
10. X.Z. Su, J. Chen, T. Mizushima, T. Kuroda, and T. Tsuchiya AbeM, an H+-coupled Acinetobacter baumannii multidrug efflux pump belonging to the MATE family of transporters Antimicrob Agents Chemother 49 2005 4362 4364
11. A. Robicsek, G.A. Jacoby, and D.C. Hooper The worldwide emergence of plasmid-mediated quinolone resistance Lancet Infect Dis 6 2006 629 640
12. W. Yau, R.J. Owen, A. Poudyal, J.M. Bell, J.D. Turnidge, and H.H. Yu Colistin hetero-resistance in multidrug-resistant Acinetobacter baumannii clinical isolates from the Western Pacific region in the SENTRY antimicrobial surveillance programme J Infect 58 2009 138 144
13. L.L. Dent, D.R. Marshall, S. Pratap, and R.B. Hulette Multidrug resistant Acinetobacter baumannii: a descriptive study in a city hospital BMC Infect Dis 10 2010 196
14. L. Morata, N. Cobos-Trigueros, J.A. Martinez, A. Soriano, M. Almela, and F. Marco Influence of multidrug resistance and appropriate empirical therapy on the 30-day mortality rate of Pseudomonas aeruginosa bacteremia Antimicrob Agents Chemother 56 2012 4833 4837
15. A. Tabah, D. Koulenti, K. Laupland, B. Misset, J. Valles, and F. Bruzzi de Carvalho Characteristics and determinants of outcome of hospital-acquired bloodstream infections in intensive care units: the EUROBACT International Cohort Study Intensive Care Med 38 2012 1930 1945
16. A. Nagayama, K. Yamaguchi, K. Watanabe, M. Tanaka, I. Kobayashi, and Z. Nagasawa Final report from the Committee on Antimicrobial Susceptibility Testing, Japanese Society of Chemotherapy, on the agar dilution method (2007) J Infect Chemother 14 2008 383 392
17. Clinical and Laboratory Standards Institute Performance standards for antimicrobial susceptibility testing; twenty-third informational supplement. Document M100-S23. 2013 CLSI Wayne, PA
18. T. Akasaka, S. Kurosaka, Y. Uchida, M. Tanaka, K. Sato, and I. Hayakawa Antibacterial activities and inhibitory effects of sitafloxacin (DU-6859a) and its optical isomers against type II topoisomerases Antimicrob Agents Chemother 42 1998 1284 1287
19. L.M. Fisher, and X.S. Pan Methods to assay inhibitors of DNA gyrase and topoisomerase IV activities Methods Mol Med 142 2008 11 23
20. R. Gaynes, J.R. Edwards, and National Nosocomial Infections Surveillance System Overview of nosocomial infections caused by Gram-negative bacilli Clin Infect Dis 41 2005 848 854
21. J.B. Northwood, C. Couturier, S. Brown, D. Knight, and I. Morrissey Analysis of quinolone-resistant Streptococcus pneumoniae collected from PROTEKT studies between 2000 and 2007 Clin Microbiol Infect 16 2010 S494
22. Y. Yang, M. Liao, W.M. Gu, K. Bell, L. Wu, and N.F. Eng Antimicrobial susceptibility and molecular determinants of quinolone resistance in Neisseria gonorrhoeae isolates from Shanghai J Antimicrob Chemother 58 2006 868 872
23. E.A. Donegan, D.N. Wirawan, P. Muliawan, J. Schachter, J. Moncada, and M. Parekh Fluoroquinolone-resistant Neisseria gonorrhoeae in Bali, Indonesia: 2004 Sex Transm Dis 33 2006 625 629
24. I. Linhares, T. Raposo, A. Rodrigues, and A. Almeida Frequency and antimicrobial resistance patterns of bacteria implicated in community urinary tract infections: a ten-year surveillance study (2000-2009) BMC Infect Dis 13 2013 19
25. J. Deane, A. Simenauer, Y. Ge, P.B. Eckburg, and D. Sahm In vitro activity of KPI-10 against clinically important Gram-positive bacteria 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) 9-12 September 2012; San Francisco, CA. 2012 American Society for Microbiology Washington, DC [abstract F-2047]
26. J. Deane, A. Simenauer, Y. Ge, P.B. Eckburg, and D. Sahm In vitro activity of KPI-10 against clinically important Gram-negative bacteria 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) 9-12 September 2012; San Francisco, CA. 2012 American Society for Microbiology Washington, DC [abstract F-2046]
27. P.K. Lindgren, A. Karlsson, and D. Hughes Mutation rate and evolution of fluoroquinolone resistance in Escherichia coli isolates from patients with urinary tract infections Antimicrob Agents Chemother 47 2003 3222 3232
28. Y. Kuramoto, Y. Ohshita, J. Yoshida, A. Yazaki, M. Shiro, and T. Koike A novel antibacterial 8-chloroquinolone with a distorted orientation of the N1-(5-amino-2,4-difluorophenyl) group J Med Chem 46 2003 1905 1917
29. H. Amano, H. Aoi, K. Sakata, K. Inokuma, D. Kazamori, and Y. Itoh In vivo activities of KPI-10, a novel fluoroquinolone (FQ), in mouse systemic and local infection models caused by multidrug- and FQ-R resistant pathogens 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) 9-12 September 2012; San Francisco, CA. 2012 American Society for Microbiology Washington, DC [abstract F-2055]
30. P.B. Eckburg, Y. Ge, V. Jiang, T. Kilfoil, and G.H. Talbot Safety & pharmacokinetics of KPI-10, a novel fluoroquinolone, in healthy adults receiving single-dose oral administrations 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) 9-12 September 2012; San Francisco, CA. 2012 American Society for Microbiology Washington, DC [abstract A-1952]